Singapore Cancer Diagnostics Startup Gets $77 Million in Funding
Yoolim Lee, Bloomberg News
(Bloomberg) Singaporean biotechnology startup MiRXES Pte raised $77 million from investors led by CR-CP Life Science Fund to deliver early detection tests for cancer and other diseases.
Other backers in the Series C funding round include Rock Springs Capital, EDBI, CCB International Holdings Ltd. and Keytone Ventures, the company said in a statement. The round, which brings the total amount of money raised to date to $120 million, values the seven-year-old startup at $500 million, according to a person with knowledge of the matter who asked not to be identified.
SG s MiRXES raises $77m Series C round led by CR-CP Life Science Fund dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.
AlleyWatch
Armed with some data from our friends at CrunchBase, I broke down the largest US startup funding rounds from April 2021. I have included some additional information such as industry, company description, round type, founders, and total equity funding raised to further the analysis. The TechWatch Media Group audience is driving progress and innovation on a global scale. With its regional media properties (NYC Tech, LA Tech, London Tech, Paris Tech, Boston Tech) TechWatch Media Group is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including strategic brand placement in a high-visibility, lead generation, and building thought leadership among the vast majority of key influencers in the business community and beyond. Learn more about running a digital campaign that will return your investment here.